公司資料
Silence Therapeutics 股價、新聞與催化劑
- 股票代碼:
- SLN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United Kingdom
股票表現
9.83 USD (-3.06%)
收盤價
最後更新: 2026年10月6日
301M USD
市值
股價為何變動
截至 2026年10月6日，SLN 下跌 3.06%，收於 $9.83。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Silence Therapeutics is an RNA interference company focused on targeted gene silencing. Its story is built around translating RNAi into precision medicines for cardiovascular and hematologic disease.
所在地與產業分類
Silence Therapeutics is headquartered in the United Kingdom and listed on NASDAQ. It sits in RNA therapeutics and platform biotechnology.
商業模式特徵
The company depends on translational validation, clinical progress, and the ability to turn RNAi science into durable therapeutic value. Investors watch data, partnerships, and pipeline execution.
生技產業定位
Silence occupies a premium RNAi niche within biotech. The stock is sensitive to whether the platform can keep validating beyond the first wave of programs.
未來催化劑
- Silence Therapeutics’ catalysts are RNAi-platform programs and any clinical update that shows the delivery / target-silencing story still has real momentum. The company remains very platform-dependent.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。